Johnson & Johnson JNJ.MX · Stock Open Johnson & Johnson in new tab
Johnson & Johnson Analysis (JNJ.MX)
Is Johnson & Johnson a good investment? Johnson & Johnson (JNJ.MX) is currently trading at 4527.43 MXN.
In terms of valuation, the stock trades at a P/E ratio of 30.99. This high multiple suggests investors have priced in significant future growth expectations.
For income investors, Johnson & Johnson pays a dividend yield of 1.97%. With a payout ratio of 61%, the dividend appears sustainable.
Investor FAQ
Does Johnson & Johnson pay a dividend?
Yes, it pays an annual dividend of 90.84 MXN (1.97% yield).
What asset class is Johnson & Johnson?
Johnson & Johnson is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.
Company Profile
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
| Year | Total Dividends |
|---|---|
| ▸2027 |
71.15 MXN
|
| Aug. 24, 2027 (estimated) | 23.9162 |
| May 25, 2027 (estimated) | 23.9162 |
| Feb. 23, 2027 (estimated) | 23.3188 |
| ▸2026 |
90.68 MXN
|
| Nov. 24, 2026 (estimated) | 23.2023 |
| Aug. 25, 2026 | 22.7197 |
| May 26, 2026 | 22.7197 |
| Feb. 24, 2026 | 22.0415 |
| ▸2025 |
87.15 MXN
|
| Nov. 25, 2025 | 22.0415 |
| Aug. 26, 2025 | 22.0415 |
| May 27, 2025 | 22.0415 |
| Feb. 18, 2025 | 21.0242 |
| ▸2024 |
83.25 MXN
|
| Nov. 26, 2024 | 21.0242 |
| Aug. 27, 2024 | 21.0242 |
| May 20, 2024 | 21.0242 |
| Feb. 16, 2024 | 20.1765 |
| ▸2023 |
79.69 MXN
|
| Nov. 21, 2023 | 20.1765 |
| Aug. 25, 2023 | 20.1765 |
| May 22, 2023 | 20.1765 |
| Feb. 17, 2023 | 19.1592 |
| ▸2022 |
75.45 MXN
|
| Nov. 22, 2022 | 19.1592 |
| Aug. 22, 2022 | 19.1592 |
| May 23, 2022 | 19.1592 |
| Feb. 18, 2022 | 17.9723 |
| ▸2021 |
71.04 MXN
|
| Nov. 22, 2021 | 17.9723 |
| Aug. 23, 2021 | 17.9723 |
| May 24, 2021 | 17.9723 |
| Feb. 22, 2021 | 17.1246 |
| ▸2020 |
67.48 MXN
|
| Nov. 23, 2020 | 17.1246 |
| Aug. 24, 2020 | 17.1246 |
| May 22, 2020 | 17.1246 |
| Feb. 24, 2020 | 16.1073 |
| ▸2019 |
63.58 MXN
|
| Nov. 25, 2019 | 16.1073 |
| Aug. 26, 2019 | 16.1073 |
| May 24, 2019 | 16.1073 |
| Feb. 25, 2019 | 15.2595 |
| ▸2018 |
60.02 MXN
|
| Nov. 26, 2018 | 15.2595 |
| Aug. 27, 2018 | 15.2595 |
| May 25, 2018 | 15.2595 |
| Feb. 26, 2018 | 14.2422 |
| ▸2017 |
42.05 MXN
|
| Nov. 27, 2017 | 14.2422 |
| Aug. 25, 2017 | 14.2422 |
| Feb. 24, 2017 | 13.5640 |
| ▸2016 |
53.41 MXN
|
| Nov. 18, 2016 | 13.5640 |
| Aug. 19, 2016 | 13.5640 |
| May 20, 2016 | 13.5640 |
| Feb. 19, 2016 | 12.7162 |
| ▸2015 |
50.02 MXN
|
| Nov. 20, 2015 | 12.7162 |
| Aug. 21, 2015 | 12.7162 |
| May 21, 2015 | 12.7162 |
| Feb. 20, 2015 | 11.8685 |
| ▸2014 |
46.80 MXN
|
| Nov. 21, 2014 | 11.8685 |
| Aug. 22, 2014 | 11.8685 |
| May 22, 2014 | 11.8685 |
| Feb. 21, 2014 | 11.1903 |
| ▸2013 |
43.91 MXN
|
| Nov. 22, 2013 | 11.1903 |
| Aug. 28, 2013 | 11.1903 |
| May 29, 2013 | 11.1903 |
| Feb. 22, 2013 | 10.3426 |
| ▸2012 |
50.36 MXN
|
| Nov. 23, 2012 | 10.3426 |
| Aug. 24, 2012 | 10.3426 |
| May 24, 2012 | 10.3426 |
| Feb. 29, 2012 | 9.6644 |
| Feb. 24, 2012 | 9.6644 |
| ▸2011 |
47.30 MXN
|
| Nov. 25, 2011 | 9.6644 |
| Aug. 26, 2011 | 9.6644 |
| May 26, 2011 | 9.6644 |
| March 2, 2011 | 9.1557 |
| Feb. 25, 2011 | 9.1557 |
| ▸2010 |
35.78 MXN
|
| Dec. 1, 2010 | 9.1557 |
| Aug. 27, 2010 | 9.1557 |
| May 27, 2010 | 9.1557 |
| Feb. 19, 2010 | 8.3080 |
| ▸2009 |
32.72 MXN
|
| Nov. 20, 2009 | 8.3080 |
| Aug. 21, 2009 | 8.3080 |
| May 21, 2009 | 8.3080 |
| Feb. 20, 2009 | 7.7993 |
| ▸2008 |
30.43 MXN
|
| Nov. 21, 2008 | 7.7993 |
| Aug. 22, 2008 | 7.7993 |
| May 22, 2008 | 7.7993 |
| Feb. 22, 2008 | 7.0363 |
| ▸2007 |
27.47 MXN
|
| Nov. 23, 2007 | 7.0363 |
| Aug. 24, 2007 | 7.0363 |
| May 24, 2007 | 7.0363 |
| Feb. 23, 2007 | 6.3581 |
| ▸2006 |
24.67 MXN
|
| Nov. 24, 2006 | 6.3581 |
| Aug. 25, 2006 | 6.3581 |
| May 25, 2006 | 6.3581 |
| Feb. 24, 2006 | 5.5952 |
| ▸2005 |
21.62 MXN
|
| Nov. 18, 2005 | 5.5952 |
| Aug. 19, 2005 | 5.5952 |
| May 13, 2005 | 5.5952 |
| Feb. 11, 2005 | 4.8322 |
| ▸2004 |
18.57 MXN
|
| Nov. 12, 2004 | 4.8322 |
| Aug. 13, 2004 | 4.8322 |
| May 14, 2004 | 4.8322 |
| Feb. 12, 2004 | 4.0692 |
| ▸2003 |
8.14 MXN
|
| Nov. 14, 2003 | 4.0692 |
| Aug. 15, 2003 | 4.0692 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Johnson & Johnson | Aug 25, 2026 | Paid | 22.7197 MXN |
| Johnson & Johnson | May 26, 2026 | Paid | 22.7197 MXN |
| Johnson & Johnson | Feb 24, 2026 | Paid | 22.041498 MXN |
| Johnson & Johnson | Nov 25, 2025 | Paid | 22.041498 MXN |
Community Discussion